• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Bare-Metal or Covered SFA Stents: Still a struggle!

  • Tue, 8/17/10 - 10:19am
  • 2744 reads
  • 0 comments

Smoking cessation and exercise regimens are the textbook answer to the treatment of patients with claudication symptoms. Surgical bypass can be complicated by wound-healing issues, graft thrombosis, etc. In light of this, the traditional approach to superficial femoral artery (SFA) disease is nonoperative, unless the patient has claudication that is debilitating and prevents the patient from performing their job appropriately.

Percutaneous therapy has changed our opinion of claudication. I (and many others) have become very aggressive about catheter-based approaches to SFA disease. My preference is to treat SFA disease with an angioplasty and stent approach. I utilize atherectomy in only very select circumstances. I have used several different varieties of bare-metal stents with good results. But, stents are not perfect, and I want to use a recent case to highlight some deficiencies.

I treated an 80-year-old man with some mild cardiac disease with an angioplasty and stent for a long-segment SFA occlusion. His ankle index initially improved from 0.57 to 0.81. His symptoms improved significantly. In just 3 months, he presented with recurrent symptoms, and a duplex exam revealed multiple stenoses within the stented segment. I performed a repeat angioplasty with a cutting-balloon technology. Again, the index improved and his symptoms resolved. Again, in a short time, he presented with recurrent symptoms. I performed an angiogram and re-lined the entire stented region with covered stent technology. Again, he did well for a short time. I recently performed an angiogram when he presented with a reduced index and I found the entire stented area to be occluded. I debated between mechanical thrombectomy or lytic treatment, but decided to leave the area alone for now.

I know we all deal with the frustration of treating SFA disease. Thankfully, this gentleman has stable, short-distance claudication and has not developed rest pain or limb-threatening ischemia. I am hoping to not have to perform a surgical bypass.

How do you deal with this?

_______________________________________________________________________________________________________

Ross Milner, MD, FACS

Ross Milner, MD, FACS is associate professor of surgery at Loyola University Chicago Stritch School of Medicine. He was recruited to Loyola from Emory University School of Medicine in Atlanta, where he was associate professor of surgery.

Dr. Milner graduated Cum Laude from the University of Pennsylvania, where he also completed medical school. He was chief resident in surgery at the Hospital of the University of Pennsylvania. He completed fellowships at the University of Pennsylvania and University Medical Center in Utrecht in the Netherlands. Dr. Milner is currently Chief of the Division of Vascular Surgery and Endovascular Therapy at Loyola University Medical Center, Stritch School of Medicine in Chicago, Illinois.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications